Mark Leibman

Mark Leibman is the Regulatory Affairs Intelligence Director at AstraZeneca, specializing in oncology. With a strong background in biotechnology and biological products, they previously served as Vice President of Regulatory and Government Affairs at Pebble Labs Inc., where they led regulatory initiatives for agricultural microbial solutions. Prior to that, Mark held various roles at Bayer, including Global Biotechnology Regulatory Affairs Strategy Lead, where they developed cohesive strategies for biotechnology-derived product approvals. Mark is currently pursuing a B.A. in Biochemistry and Molecular Biology at the University of Colorado Boulder and a Ph.D. in Microbiology & Molecular Genetics at Harvard University.